Islet Transplantation for Brittle Type 1 Diabetes: The UIC Protocol - Gangemi, A.; Salehi, P.; Hatipoglu, B.; Martellotto, J.; Barbaro, B.; Kuechle, J. B.; Qi, M.; Wang, Y.; Pallan, P.; Owens, C.; Bui, J.; West, D.; et al. (American journal of transplantation, 2008)
Keywords: Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Applied cell therapy and gene therapy; Biological and medical sciences; Clinical Protocols; Diabetes Mellitus, Type 1 - surgery; Diabetes. Impaired glucose tolerance; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Etanercept; Etiopathogenesis. Screening. Investigations. Target tissue resistance; Exenatide; Humans; Hypoglycemic Agents - therapeutic use; Immunoglobulin G - therapeutic use; Immunosuppressive Agents - therapeutic use; Islet transplantation; Islets of Langerhans Transplantation; Medical sciences; Peptides - therapeutic use; Prospective Studies; Receptors, Tumor Necrosis Factor - therapeutic use; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases; Transfusions. Complications. Transfusion reactions. Cell and gene therapy; transplantation cell therapy; transplantation research; type I diabetes; Venoms - therapeutic use; Endocrinopathy; Immunopathology; Cell therapy; Langerhans islet; Homograft; Autoimmune disease; Transplantation; Homotransplantation; Treatment; Type 1 diabetes; Surgery; Scientific research; transplantation cell therapy; Islet transplantation; transplantation research; Graft; type I diabetes; Endocrine pancreas